Filings

5 documents · 21 matches

1. APUS Apimeds Pharmaceuticals US, Inc. 10-K 2026-05-04

   Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   Going Concern Assessment. Management’s assessment of the Company’s ability to continue as a going concern requires significant judgment
   10 matches in this document Show context Copy citation

2. APUS Apimeds Pharmaceuticals US, Inc. 8-K/A 2026-02-17

   Note 2. Liquidity and Cash Resources

   going concern within one year after the date the financial statements are issued, as required under ASC 205-40. Based
   2 matches in this document Show context Copy citation

3. APUS Apimeds Pharmaceuticals US, Inc. 8-K/A 2026-02-17

   Note 2. Liquidity and Cash Resources

   going concern within one year after the date the financial statements are issued, as required under ASC 205-40. Based
   2 matches in this document Show context Copy citation

4. APUS Apimeds Pharmaceuticals US, Inc. 10-Q 2026-05-26

   Item 1 · Note 2. Basis of Presentation and Summary of Significant Accounting Policies

   going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of March
   1 match in this document Show context Copy citation

5. APUS Apimeds Pharmaceuticals US, Inc. 10-Q 2026-08-14

   Item 1 · Note 1. Description of Business

   going-concern discussion above, are effected from time to time out of that non-current position and do not, individually
   6 matches in this document Show context Copy citation